COVID-19 Project Utilization
| Project | Number of Jobs Run To-Date | Node Hours Used To-Date | Number of Jobs Running Now | Nodes in Use Now | |
|---|---|---|---|---|---|
| Cleveland Clinic COVID-19 Computational Science Projects Requiring Additional Compute Needs PI: Feixiong Cheng, Cleveland Clinic |
12 | 67 | 1 | 1 | |
| Computational Systems Biology for Viral Detection and Classification of Emerging Infections and Rapid Identification of Causal Agents and Mechanisms PI: Daniel Jacobson, Oak Ridge National Laboratory (ORNL) |
1,086 | 216,615 | 3 | 6 | |
| COVID research PI: Bobby Sumpter, Oak Ridge National Laboratory (ORNL) |
43 | 3,270 | 1 | 256 | |
| COVID-19: Molecular Simulations and Underexplored Drug Targets PI: Jason Crain, International Business Machines Corporation (IBM) |
1 | 0 | 0 | 0 | |
| COVID-19: Submodular Optimization & Graph Clustering Approaches for Designing Effective Vaccination Strategies PI: Mahantesh Halappanavar, Pacific Northwest National Laboratory |
159 | 1,751 | 1 | 256 | |
| Determining the contribution of glycosylation to SARS-CoV-2 S-protein conformational dynamics PI: James Gumbart, Georgia Institute of Technology |
38 | 331 | 2 | 4 | |
| Dissecting inhibitor impacts on viral RNA polymerase and fidelity control of RNA synthesis in SARS-CoV-2 PI: Jin Yu, University of California - Irvine |
101 | 164 | 1 | 1 | |
| Drug Discovery for COVID-19 PI: Jeremy Smith, University of Tennessee |
4,427 | 258,995 | 1 | 10 | |
| Forecasting COVID-19 Infections across the US PI: Jesse Piburn, Oak Ridge National Laboratory (ORNL) |
0 | 0 | 0 | 0 | |
| Molecular Simulations of Complexes of SARS-CoV Spike Proteins with Human Receptor ACE2 PI: Sameer Varma, University of South Florida |
1,176 | 4,154 | 2 | 4 | |
| Physical Models of COVID-19 Related Proteins PI: Ken Dill, State University of New York at Stony Brook |
44 | 219 | 1 | 5 | |
| Prediction of synergistic drug combinations for treatment of COVID-19 PI: Jennifer Diaz, Icahn School of Medicine at Mount Sinai |
0 | 0 | 0 | 0 | |
| Structural Modeling of COVID-19 with HP PI: Debsindhu Bhowmik, Oak Ridge National Laboratory (ORNL) |
2,027 | 51,402 | 35 | 70 | |
| Targeting the SARS-CoV-2 Proteome with Artificial Intelligence (AI) Driven Small Molecule Design and Screening PI: Rick Stevens, Argonne National Laboratory |
879 | 25,138 | 1 | 1 | |
| Using MD and QM/MM to improve drug candidates for nCoV-19 targets PI: Gerardo Cisneros, University of North Texas |
95 | 791 | 3 | 12 | |
| 10,088 | 562,898 | 52 | 626 |
OLCF Now
Announcements & Events
Center Updates
Upcoming Events
OLCF Support
Computing at the OLCF
All the information you’ll need about getting an account, requesting a project, connecting and more.
The definitive source for information on a particular OLCF system including resource specific specs, user guides, and best practices.
Archives of training materials, hands-on technical tutorial, and videos detailing how to use OLCF resources and services
Descriptions, usage information, and version availability of all software packages in use at the OLCF.
A comprehensive guide of all official policies of the OLCF.
Documents and forms for requesting project allocations, user accounts, software and more.
User-centric web application to view and report your project allocation usage in various ways.
Center Status
Up since May 19, 2020
Next 10 days scheduled downtimes
Up since Mar 27, 2020
Next 10 days scheduled downtimes
Up since May 26, 2020
Next 10 days scheduled downtimes
OLCF News
Discover More
Developing a Quantum Community
The OLCF’s Quantum Computing User Program connects researchers to advanced resources, paves way for next-gen computational science
OLCF Names New Director of Science
ORNL astrophysicist Bronson Messer will lead the supercomputer center’s pursuit of scientific discovery
Knocking Out Drug Side Effects with Supercomputing
Stanford team employs Summit, the world’s most powerful supercomputer, in drug design efforts
Supercomputing Aids Scientists Seeking Therapies for Deadly Bacterial Disease
Summit captures “in between” stages of bacterial protein movements, giving researchers hope for finding drug targets for rabbit fever
